Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FLTN7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,687
Award facts
- Contract value 100% obligated
- $13,687.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $13,687 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, awarded on January 16, 2026, with an ultimate completion date of February 9, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical products and medical consumables to military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, holding contract SPE2DR with a $499.999 billion ceiling and a completion date of December 31, 2036. The contractor's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices, positioning it to fulfill diverse and specialized pharmaceutical requirements across the Department of Defense healthcare system. The firm's consistent performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division underscores its capability to support recurring medical supply needs across military installations globally.
Quick answers
Who was awarded contract SPE2DR26FLTN7?
SPE2DR26FLTN7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FLTN7 worth?
The government has obligated $13,687 on SPE2DR26FLTN7.
Is contract SPE2DR26FLTN7 an order under another contract?
Yes. SPE2DR26FLTN7 is a delivery order under SPE2DR25D9766, an indefinite delivery contract.
Was contract SPE2DR26FLTN7 competed?
The extent of competition for SPE2DR26FLTN7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award